Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Inventory (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Inventory for 12 consecutive years, with $408794.0 as the latest value for Q4 2025.

  • On a quarterly basis, Inventory fell 37.85% to $408794.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $408794.0, a 37.85% decrease, with the full-year FY2025 number at $408794.0, down 37.85% from a year prior.
  • Inventory was $408794.0 for Q4 2025 at Cryo Cell International, down from $655254.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.1 million in Q3 2023 to a low of $408794.0 in Q4 2025.
  • A 5-year average of $800991.2 and a median of $842596.5 in 2021 define the central range for Inventory.
  • Peak YoY movement for Inventory: rose 15.62% in 2023, then crashed 37.85% in 2025.
  • Cryo Cell International's Inventory stood at $921213.0 in 2021, then decreased by 7.6% to $851230.0 in 2022, then decreased by 9.67% to $768877.0 in 2023, then fell by 14.46% to $657703.0 in 2024, then plummeted by 37.85% to $408794.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Inventory are $408794.0 (Q4 2025), $655254.0 (Q3 2025), and $676764.0 (Q2 2025).